Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
evobrutinib
(M2951) /
EMD Serono
Welcome,
Profile
Billing
Logout
5 Diseases
3 Trials
3 Trials
423 News
«
1
2
3
4
5
6
|||||
|||||
evobrutinib
(M2951) /
EMD Serono
New P2 trial:
MS200527-0086: A Study of Efficacy and Safety of M2951 in Participants With Relapsing Multiple Sclerosis
(clinicaltrials.gov) - Nov 29, 2016
P2
, N=250, Not yet recruiting,
Sponsor: EMD Serono Research & Development Institute, Inc.
||||||||||
evobrutinib
(M2951) /
EMD Serono
Enrollment open:
EMR200527-002: MSC2364447C Phase 1b in Systemic Lupus Erythematosus
(clinicaltrials.gov) - Aug 11, 2016
P1b
, N=24, Recruiting,
Sponsor: EMD Serono Research & Development Institute, Inc.
Active, not recruiting --> Recruiting
||||||||||
evobrutinib
(M2951) /
EMD Serono
Enrollment closed, Phase classification:
EMR200527-002: MSC2364447C Phase 1b in Systemic Lupus Erythematosus
(clinicaltrials.gov) - Jul 29, 2016
P1b
, N=24, Active, not recruiting,
Sponsor: EMD Serono Research & Development Institute, Inc.
Active, not recruiting --> Recruiting Recruiting --> Active, not recruiting | Phase classification: P1 --> P1b
||||
||||||
evobrutinib
(M2951) /
EMD Serono
Enrollment open:
MS200527-0081: Safety and Efficacy Study of M2951 in Participants With Rheumatoid Arthritis
(clinicaltrials.gov) - Jul 15, 2016
P2a
, N=64, Recruiting,
Sponsor: EMD Serono
Recruiting --> Active, not recruiting | Phase classification: P1 --> P1b Not yet recruiting --> Recruiting
|||||
|||||
evobrutinib
(M2951) /
EMD Serono
New P2a trial:
MS200527-0081: Safety and Efficacy Study of M2951 in Participants With Rheumatoid Arthritis
(clinicaltrials.gov) - May 26, 2016
P2a
, N=64, Not yet recruiting,
Sponsor: EMD Serono
||||||||||
evobrutinib
(M2951) /
EMD Serono
Enrollment open:
EMR200527-002: MSC2364447C Phase 1b in Systemic Lupus Erythematosus
(clinicaltrials.gov) - Nov 11, 2015
P1
, N=24, Recruiting,
Sponsor: EMD Serono
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
|
|||||||||
evobrutinib
(M2951) /
EMD Serono
New P1 trial:
EMR200527-002: MSC2364447C Phase 1b in Systemic Lupus Erythematosus
(clinicaltrials.gov) - Sep 1, 2015
P1
, N=24, Not yet recruiting,
Sponsor: EMD Serono